Bernier-Jean Amélie, Beaubien-Souligny William, Goupil Rémi, Madore François, Paquette François, Troyanov Stéphan, Bouchard Josée
Department of Medicine, Division of Nephrology, Sacre-Coeur Hospital of Montreal, 5400 Gouin Blvd West, Montreal, Quebec, H4J 1C5, Canada.
Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
BMC Nephrol. 2017 Apr 28;18(1):141. doi: 10.1186/s12882-017-0552-3.
Missing preadmission serum creatinine (SCr) values are a common obstacle to assess acute kidney injury (AKI) diagnosis and outcomes. The Kidney Disease Improving Global Outcomes (KDIGO) guidelines suggest using a SCr computed from the Modification of Diet in Renal Disease (MDRD) with an estimated glomerular filtration rate of 75 ml/min/1.73 m. We aimed to identify the best surrogate method for baseline SCr to assess AKI diagnosis and outcomes.
We compared the use of 1) first SCr at hospital admission 2) minimal SCr over 2 weeks after intensive care unit admission 3) MDRD computed SCr and 4) Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) computed SCr to assess AKI diagnosis and outcomes. We then performed multilinear regression models to predict preadmission SCr and imputation strategies to assess AKI diagnosis.
Our one-year retrospective cohort study included 1001 critically ill adults; 498 of them had preadmission SCr values. In these patients, AKI incidence was 25.1% using preadmission SCr. First SCr had the best agreement for AKI diagnosis (22.5%; kappa = 0.90) and staging (kappa = 0.81). MDRD, CKD-EPI and minimal SCr overestimated AKI diagnosis (26.7%, 27.1% and 43.2%;kappa = 0.86, 0.86 and 0.60, respectively). However, MDRD and CKD-EPI computed SCr had a better sensitivity than first SCr for AKI (93% and 94% vs. 87%). Eighty-eight percent of patients experienced renal recovery at least 3 months after hospital discharge. All methods except the first SCr significantly underestimated the percentage of renal recovery. In a multivariate model, age, male gender, hypertension, heart failure, undergoing surgery and log first SCr best predicted preadmission SCr (adjusted R = 0.56). Imputation methods with first SCr increased AKI incidence to 23.9% (kappa = 0.92) but not with MDRD computed SCr (26.7%;kappa = 0.89).
In our cohort, first SCr performed better for AKI diagnosis and staging, as well as for renal recovery after hospital discharge than MDRD, CKD-EPI or minimal SCr. However, MDRD SCr and CKD-EPI SCr improved AKI diagnosis sensitivity. Imputation methods minimally increased agreement for AKI diagnosis.
入院前血清肌酐(SCr)值缺失是评估急性肾损伤(AKI)诊断和预后的常见障碍。改善全球肾脏病预后组织(KDIGO)指南建议使用根据肾脏病饮食改良(MDRD)公式计算得出的SCr,估算肾小球滤过率为75 ml/min/1.73m²。我们旨在确定评估AKI诊断和预后时基线SCr的最佳替代方法。
我们比较了以下方法在评估AKI诊断和预后中的应用:1)入院时首次测得的SCr;2)重症监护病房入院后2周内的最低SCr;3)MDRD公式计算的SCr;4)慢性肾脏病流行病学协作组(CKD-EPI)公式计算的SCr。然后我们进行多线性回归模型以预测入院前SCr,并采用插补策略评估AKI诊断。
我们的一年回顾性队列研究纳入了1001例危重症成人;其中498例有入院前SCr值。在这些患者中,使用入院前SCr时AKI发病率为25.1%。首次测得的SCr在AKI诊断方面一致性最佳(22.5%;kappa值 = 0.90),在分期方面一致性也最佳(kappa值 = 0.81)。MDRD公式、CKD-EPI公式计算的SCr以及最低SCr均高估了AKI诊断(分别为26.7%、27.1%和43.2%;kappa值分别为0.86、0.86和0.60)。然而,MDRD公式和CKD-EPI公式计算的SCr对AKI的诊断敏感性高于首次测得的SCr(分别为93%和94%,而首次测得的SCr为87%)。88%的患者在出院后至少3个月实现了肾功能恢复。除首次测得的SCr外,所有方法均显著低估了肾功能恢复的比例。在多变量模型中,年龄、男性、高血压、心力衰竭、接受手术以及首次测得的SCr的对数值是入院前SCr的最佳预测指标(调整后R² = 0.56)。采用首次测得的SCr的插补方法使AKI发病率增至23.9%(kappa值 = 0.92),而采用MDRD公式计算的SCr的插补方法则未达到这一效果(26.7%;kappa值 = 0.89)。
在我们的队列中,对于AKI诊断、分期以及出院后的肾功能恢复情况,首次测得的SCr比MDRD公式、CKD-EPI公式计算的SCr或最低SCr表现更好。然而,MDRD公式计算的SCr和CKD-EPI公式计算的SCr提高了AKI诊断的敏感性。插补方法对AKI诊断一致性的提高作用最小。